Try Jim Cramer's Action Alerts PLUS
CLICK HERE NOW
Beat the Street

Top Rocket Stocks for Week of March 17

James Altucher

03/17/08 - 11:16 AM EDT
Updated from 7:01 a.m. EDT

Since the start of the Rocket Stocks weekly column, I've been putting together a list of 10 stocks each week that I believe have the potential to move higher in the coming week.

With the market's recent volatility, the best way to trade lately is finding beaten-down stocks that have both short-term growth potential and strong fundamentals.

With such volatile stocks, all you really need is a small ounce of hope for the shorts to start panicking and the momentum drivers to start piling in, driving up share price.

Back testing on the Nasdaq 100 shows that a stock that drops 10% in a day will on average be 2% higher one week later. Conversely, if a stock is up 10% in a day, it is usually down one week later.

Altucher: Stocks I'd Buy in a Recession

Before we take a look at this week's Rocket Stocks portfolio -- which includes names like Goldman Sachs GS, Tesoro TSO and Southern Union SUG, let's see how the last week's picks fared.

Now let's look this week's Rocket Stocks portfolio.

First up this week is Aluminum Corp of China ACH, which has a forward price-to-earnings (P/E) ratio of 8.8 and a P/E-to-growth (PEG) ratio of 1.1.

Down $50 from its all-time high of about $90 a share hit back in October, Aluminum China has been oversold, and thus I am looking for a snapback rally into this week's preliminary earnings report.

Aluminum China operates in two bull markets: China and aluminum, and although it represents a much riskier than, say, Aloca AA, Aluminum China has the potential to ramp more than 10 points in a single day.

Companies like Kaiser Aluminum KALU, Century Aluminum CENX and Alcoa all handily beat their latest earnings estimates, which could help Aluminum China's chances to deliver an upside surprise.

Also worth keeping an eye on is small-cap biotech company Enzon Pharmaceuticals ENZN. Carl Icahn, who holds a 6.93% stake in the company, has reportedly suggested to management that they "consider possible alternative strategies," which basically means that the activist investor believes Enzon is substantially undervalued.

Icahn stated his plans Friday midafternoon, during the height of the Bear Stearns BSC mess. Overlooked by Wall Street, Enzon Pharma has the potential to move much higher in the coming week.

And with a third of its float sold short, Enzon has a short ratio of nearly 21. So on any positive news, the stock could really surge.

For more detailed analysis and the rest of this week's picks, check out the please click here.

As always, to find the snapbacks and potential breakouts on a regular basis, check out these Stockpickr portfolios, which I use in my own research each week:

One final place to frequent is the Answers section on Stockpickr, where ideas such as those presented in this article are thrown around daily.

Please note that due to factors including low market capitalization and/or insufficient public float, we consider Enzon Pharmaceuticals to be a small-cap stock. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.